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 Introduction 
 How cells physically organize and compartmentalize receptors 
and signaling molecules into specialized, effi cient, regulated 
networks is of critical importance to our understanding of the 
complexity and dynamics of biological processes. In this re-
gard, cholesterol and sphingolipid-enriched rafts have been 
proposed as platforms for the sorting of specific membrane 
components, such as glycosylphosphatidylinositol (GPI)-
anchored proteins, and as sites for the assembly of cytoplasmic 
signaling complexes ( Simons and Toomre, 2000 ;  Anderson and 
Jacobson, 2002 ). Recent biochemical, proteomic, and structural 
studies bolster the idea that tetraspanin-enriched microdomains 
(TEMs) at the plasma membrane play a key role in organizing 
molecular complexes with protein compositions different from 
those of typical lipid rafts ( Hemler, 2005 ;  Le Naour et al., 2006 ; 
 Min et al., 2006 ). The existence and physical properties of lipid 
rafts have been extensively studied by innovative analytical 
methods ( Kenworthy et al., 2004 ;  Sharma et al., 2004 ;  Larson 
et al., 2005 ;  Suzuki et al., 2007 ). However, the presence and mo-
lecular dynamics of TEMs on the plasma membrane of living 
cells have not been explored. 
 Tetraspanins are ubiquitous, low molecular weight proteins 
that span the plasma membrane four times and are able to organize 
themselves by homo- and heterooligomerization ( Hemler, 2005 ). 
Moreover, these molecules can simultaneously associate laterally 
VCAM-1 and ICAM-1, receptors for leukocyte inte-grins, are recruited to cell – cell contact sites on the apical membrane of activated endothelial cells. 
In this study, we show that this recruitment is independent 
of ligand engagement, actin cytoskeleton anchorage, and 
heterodimer formation. Instead, VCAM-1 and ICAM-1 
are recruited by inclusion within specialized preformed 
tetraspanin-enriched microdomains, which act as endo-
thelial adhesive platforms (EAPs). Using advanced ana-
lytical ﬂ uorescence techniques, we have characterized the 
diffusion properties at the single-molecule level, nanoscale 
organization, and speciﬁ c intradomain molecular inter-
actions of EAPs in living primary endothelial cells. This 
study provides compelling evidence for the existence of 
EAPs as physical entities at the plasma membrane, dis-
tinct from lipid rafts. Scanning electron microscopy 
of immunogold-labeled samples treated with a speciﬁ c 
tetraspanin-blocking peptide identify nanoclustering 
of VCAM-1 and ICAM-1 within EAPs as a novel mecha-
nism for supramolecular organization that regulates the 
leukocyte integrin – binding capacity of both endothelial 
receptors during extravasation.
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enhance their adhesive properties during leukocyte adhesion 
to endothelium. By using advanced analytical fl uorescence 
microscopy techniques, we have determined the molecular 
characteristics, dynamics, and biophysical properties of EAPs. 
Finally, using scanning electron microscopy in combination 
with tetraspanin-blocking peptides, we show that tetraspanin 
microdomains make an essential contribution to the avidity 
regulation of endothelial adhesion receptors, fi ne-tuning their 
adhesive properties. 
 Results 
 Endothelial ICAM-1 and VCAM-1 cluster 
at the docking structure independently 
of counterreceptor engagement and actin 
anchorage 
 We have previously shown that at contact sites with adherent 
leukocytes, activated endothelial cells form three-dimensional 
actin-based docking structures that cluster VCAM-1 and ICAM-1 
( Barreiro et al., 2002 ). To analyze the dynamic recruitment of ad-
hesion molecules to these docking structures, we induced their 
formation with K562 cells expressing either   4  1 or   L  2 inte-
grins (K562   4 or K562 lymphocyte function-associated anti-
gen – 1 [LFA-1]), which adhere to activated endothelial cells via 
VCAM-1 or ICAM-1, respectively. Surprisingly, both ICAM-1 
and VCAM-1 clustered at the docking structure formed around 
either K562 clone, regardless of whether they were directly en-
gaged by their corresponding integrin receptor ( Fig. 1 A ). To as-
sess the generality of this corecruitment, we examined the docking 
structures formed with T lymphoblasts, which express both LFA-1 
and very late antigen – 4 (VLA-4); before adhesion to activated 
human umbilical vein endothelial cells (HUVECs), LFA-1 was 
blocked with a specifi c allosteric antagonist (BIRT377), or VLA-4 
was blocked with a ligand-binding inhibitor (BIO5192). In both 
cases, VCAM-1 and ICAM-1 were corecruited in a similar way 
as observed with K562 cells ( Fig. 1 B ). 
 To assess the involvement of the endothelial actin cytoskele-
ton in VCAM-1 – ICAM-1 corecruitment, we transiently transfected 
resting HUVECs with a cytoplasmic tail – truncated VCAM-1 
mutant (VCAM  Cyt). Under these conditions, HUVECs bear low 
levels of ICAM-1 and negligible levels of endogenous VCAM-1. 
Upon engagement of VCAM  Cyt by K562   4, discrete clusters 
containing VCAM  Cyt and ICAM-1 were observed around ad-
hered cells, but in no case was a well-developed three-dimensional 
structure formed ( Fig. 1 C , i). In contrast, when ICAM-1 was 
directly engaged by K562 LFA-1, a proper docking structure was 
formed, also containing VCAM  Cyt ( Fig. 1 C , ii). Likewise, well-
formed docking structures containing ICAM-1 and VCAM  Cyt 
were induced by adhered T lymphoblasts ( Fig. 1 C , iii). These data 
suggest that the engagement of one endothelial adhesion receptor 
by its corresponding leukocyte integrin corecruits the other recep-
tor toward the contact area. This coclustering must involve the ex-
tracellular or transmembrane domains of both adhesion molecules 
because it occurs with cytoplasmic tail – truncated forms. However, 
subsequent reorganization of the endothelial actin cytoskeleton 
into the protrusive cup requires actin anchorage of the cytoplasmic 
tail of the ligand-bound endothelial adhesion molecule. 
at the plasma membrane with numerous integral membrane recep-
tors, modulating their functions and organizing discrete, dynamic 
plasma membrane compartments. These partners include integ-
rins and other adhesion molecules ( Yanez-Mo et al., 1998 ; 
 Berditchevski, 2001 ;  Barreiro et al., 2005 ), CD19 – CD21 ( Cherukuri 
et al., 2004 ;  Levy and Shoham, 2005 ), major histocompatibility 
complex – peptide complexes ( Kropshofer et al., 2002 ), Fc re-
ceptors ( Moseley, 2005 ), G protein – coupled receptors ( Little et al., 
2004 ), and metalloproteinases ( Yan et al., 2002 ). Tetraspanins also 
associate intracellularly with several cytoplasmic signaling media-
tors such as type II PI4K or PKC isoforms ( Yauch and Hemler, 
2000 ;  Zhang et al., 2001 ). Apart from acting as adapters for mem-
brane organization, tetraspanins also regulate the traffi cking and 
biosynthetic processing of associated receptors ( Berditchevski and 
Odintsova, 2007 ). Although TEMs seem to be different from 
biochemically defi ned lipid rafts ( Simons and Toomre, 2000 ), they 
are not devoid of lipid interactions because tetraspanins are highly 
palmitoylated proteins that bind cholesterol and gangliosides 
( Charrin et al., 2003 ;  Yang et al., 2004 ). 
 The composition and other specifi c characteristics of 
TEMs may vary with cell type. Gene deletion, knockdown, 
overexpression, and mutation experiments have revealed key 
functional roles for tetraspanins in many fundamental physio-
logical processes, among which are egg – sperm fusion ( Le 
Naour et al., 2000 ;  Miyado et al., 2000 ), antigen presentation 
( Kropshofer et al., 2002 ;  Levy and Shoham, 2005 ;  Unternaehrer 
et al., 2007 ), viral cell entry and budding and virus-promoted 
syncytia formation ( Pileri et al., 1998 ;  Gordon-Alonso et al., 
2006 ;  Nydegger et al., 2006 ), kidney failure and tissue angio-
genesis ( Sachs et al., 2006 ;  Takeda et al., 2007 ), and cell adhe-
sion, migration, and invasion ( Yanez-Mo et al., 1998, 2008 ; 
 Chattopadhyay et al., 2003 ;  Hemler, 2003 ;  Barreiro et al., 
2005 ). Because there are few known tetraspanin ligands, it is 
very likely that these molecules exert their regulatory effects 
indirectly through their lateral binding to assorted partners. 
However, the molecular mechanisms underlying the regula-
tory activity of tetraspanins remain elusive. 
 Leukocyte extravasation from the bloodstream to sites of 
infection and infl ammation involves a dynamic interaction 
with the endothelium that is mediated by an array of leukocyte 
and endothelial cell surface receptors. This process consists of 
sequential steps of tethering, rolling, fi rm adhesion, locomo-
tion, and diapedesis, with specialized receptor/ligand pairs in-
volved in each ( Ley et al., 2007 ). Previous studies have shown 
that, to prevent leukocyte detachment under hemodynamic 
fl ow, endothelial cells form actin-based structures that cluster 
VCAM-1, ICAM-1 ( Barreiro et al., 2002 ;  Carman and Springer, 
2003 ;  van Buul et al., 2007 ), tetraspanins, and actin-binding 
proteins at the contact area with leukocytes ( Barreiro et al., 
2002, 2005 ). 
 In this study, we demonstrate that before leukocyte bind-
ing, the apical plasma membrane of living endothelial cells 
possesses specialized microdomains containing tetraspanins 
and adhesion receptors (VCAM-1 and ICAM-1), which we 
have termed endothelial adhesive platforms (EAPs). This par-
ticular kind of TEM promotes molecular aggregation at the 
nanoscopic scale (nanoclustering) of adhesion receptors to 
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fer (FRET) – fl uorescence lifetime imaging microscopy (FLIM) 
analysis. For this purpose, we generated functional VCAM-1 and 
ICAM-1 chimeras fused to monomeric EGFP (mEGFP) as donor 
and mRFP1 as acceptor. The constructs were transiently cotrans-
fected into primary HUVECs under resting conditions to prevent 
up-regulation of endogenous VCAM-1 and ICAM-1 expression. 
We then analyzed the molecular interactions at a nanometric scale 
 Analysis of homo- and heterophilic 
interactions of ICAM-1 and VCAM-1 
in living endothelial cells 
 Because cytoskeletal anchorage cannot account for adhesion 
receptor corecruitment, we investigated the potential formation 
of VCAM-1 – ICAM-1 heterodimers at the apical membrane of 
living primary endothelial cells by F ö rster resonance energy trans-
 Figure 1.  VCAM-1 and ICAM-1 are copresented 
at lymphocyte – endothelium contact sites indepen-
dently of ligand binding and actin anchorage. 
(A) K562   4 or LFA-1 was adhered (30 min) to 
TNF-  – activated HUVECs. Samples were ﬁ xed 
and double stained with anti – VCAM-1 (P8B1) and 
biotin-conjugated anti – ICAM-1 (MEM111). Confocal 
stacks were obtained, and orthogonal maximal 
projections and vertical three-dimensional recon-
structions of the whole series are displayed. (B) 
Human T lymphoblasts were pretreated (5 min) with 
10  μ M BIRT377 or 10  μ g/ml BIO5192 to inacti-
vate LFA-1 or VLA-4 and were added to TNF-  – 
activated HUVECs for 5 min. Fixed cells were 
double stained as in A. Confocal stacks were 
obtained, and a representative section from each 
treatment is shown together with its correspond-
ing colocalization histogram and a mask showing 
the distribution of double green-red pixels (marked 
regions) within the cell. (C) Resting HUVECs trans-
fected with VCAM  Cyt were incubated with K562 
  4 (i), K562 LFA-1 (ii), or T lymphoblasts (iii). 
Fixed cells were double stained with anti – VCAM-1 
(VCAM  Cyt was the only VCAM-1 species detected) 
and biotin-conjugated anti – ICAM-1. Confocal stacks 
were obtained; representative sections or vertical 
reconstructions of the whole series are displayed. 
Arrows show positions of adhered leukocytes. The 
deleted sequence in the VCAM  Cyt construct is 
shown in red below the ﬁ gure. TM, transmembrane; 
Cyt Dom, cytoplasmic domain. Bars: (A and C) 
20  μ m; (B) 10  μ m. 
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maining pixels (12%) showed positive FRETeff of 14 – 34% and 
were localized in clusters at the membrane ( Fig. 2 A ). In contrast, 
the analysis showed no signifi cant molecular interactions of the 
VCAM-1 – VCAM-1, ICAM-1 – VCAM-1, and VCAM-1 – ICAM-1 
pairs ( Fig. 2, B – D ). Thus, under these conditions, homophilic 
ICAM-1 – ICAM-1 interactions, but not VCAM-1 – VCAM-1 or 
heterophilic VCAM-1 – ICAM-1 interactions, are detected on the 
plasma membrane of living primary endothelial cells. 
between ICAM-1 – ICAM-1, VCAM-1 – VCAM-1, and ICAM-1 – 
VCAM-1 by alternately using each receptor as donor ( Fig. 2 ). 
The fl uorescence lifetime of the donor in each cotransfection was 
compared with that of singly transfected ICAM-1 – or VCAM-1 –
 mEGFP (donor standards in Fig. S1 A, available at http://www.jcb
.org/cgi/content/full/jcb.200805076/DC1). In the case of ICAM-1 –
 ICAM-1 interaction, although most pixels were below the FRET 
detection threshold (FRET effi ciency [FRETeff]  ≤ 10%), the re-
 Figure 2.  VCAM-1 and ICAM-1 do not in-
teract at the plasma membrane. Endothelial 
cells were cotransfected with mEGFP – mRFP1 
pairs (ICAM-1 – ICAM-1, VCAM-1 – VCAM-1, 
ICAM-1 – VCAM-1, and VCAM-1 – ICAM-1). 
A representative FRET – FLIM analysis using the 
phasor plot is shown for each pair. The sine (s) 
and cosine (g) transforms of the lifetime data mea-
sured in the frequency mode generate the coor-
dinate system presented in the phasor ( Digman 
et al., 2008 ). Fluorescence intensity (F. inten-
sity) images are in pseudocolor (left), and cor-
responding mEGFP lifetime distributions are 
shown in the plots after the phasor transforma-
tion (right). In each phasor plot, the green line 
represents 0% FRETeff and the red line marks 
50% FRETeff ( Caiolfa et al., 2007 ). The black 
circular cursors in the phasor plots select the 
subset of pixels shown in the correlated FLIM 
images (pink mask for positive FRET and white 
mask for negative FRET; middle). For the ICAM-
1 – ICAM-1 pair (A), most pixels lie very close 
to the green line (FRETeff  ≤ 10%; negligible), 
but 12% of pixels exhibit FRETeff of 14 – 34%. 
These positive pixels are localized in clusters, 
as shown by the FLIM image (pink mask). Other 
protein pairs (B – D) show phasor distributions 
indistinguishable from that of the negative con-
trols (Fig. S1 A, available at http://www.jcb
.org/cgi/content/full/jcb.200805076/DC1). 
a.u., arbitrary units. Bars, 20  μ m. 
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affected to a lesser extent, exhibiting a variable slowdown in 
FRAP recovery curves compared with analyses of the same 
molecules at other plasma membrane regions of similar size 
(Fig. S3 A). Statistical analyses showed that ICAM-1 engage-
ment had the greater effect on CD9 mobility, whereas CD151 
was more affected by VCAM-1 engagement (Table S2 and Fig. 
S3 A). These data thus suggest a degree of specifi city among 
tetraspanin – partner interactions within EAPs. GPI-EGFP diffu-
sion was not altered at docking structures ( Fig. 3 E ). 
 Differences in the diffusion of tetraspanins and adhesion 
receptors could be related to their differential anchorage to the 
actin cytoskeleton. We therefore analyzed the dynamics of a cy-
toplasmic tail – truncated mutant of ICAM-1 (ICAM-1  Cyt-
EGFP), which lacks actin – cytoskeleton linking activity. Freed 
of cytoskeletal constraints, this truncated ICAM-1 diffused at 
the plasma membrane more rapidly than the full-length receptor 
(Fig. S3 B). ICAM-1  Cyt-EGFP also had a faster fl uorescence 
recovery rate than the wild-type molecule at docking sites with 
K562 LFA-1 cells, indicating that stabilization of the ICAM-1 –
 LFA-1 interaction also implies anchorage of ICAM-1 to the 
endothelial F-actin cytoskeleton (Fig. S3 B). 
 To accurately estimate the diffusional features of individ-
ual EAP components, we applied fl uorescence correlation spec-
troscopy (FCS) to mEGFP-tagged ICAM-1, VCAM-1, CD9, 
and CD151 expressed in living primary human endothelial cells. 
The autocorrelation functions (ACFs) derived from fl uorescence 
intensity traces were best fi tted using an anomalous diffusion 
model. We found that all of these proteins showed a pattern of 
local diffusion confi nement, with ICAM-1 and VCAM-1 show-
ing slower overall diffusion than tetraspanins, correlating with a 
higher diffusion anomality (smaller   coeffi cient values;  Fig. 4 A ). 
Tetraspanins showed a higher relative frequency of faster diffu-
sion than adhesion receptors (Fig. S4 A, available at http://www
.jcb.org/cgi/content/full/jcb.200805076/DC1). This might indicate 
a more confi ned diffusion of VCAM-1 and ICAM-1 within EAPs 
versus a more dynamic exchange of tetraspanins among different 
microdomains. Furthermore, we found a pronounced decrease in 
the molecular mobility of CD9 within docking structures com-
pared with nude plasma membrane ( Fig. 4 B ), concurring with 
data obtained by FRAP analysis. 
 Speciﬁ city of tetraspanin – adhesion 
receptor interactions within EAPs 
 Next, we performed additional FRET – FLIM analyses in living 
endothelial cells to explore the molecular interactions among 
CD9, CD151, ICAM-1, and VCAM-1. These assays confi rmed 
the homophilic CD9 – CD9 and heterophilic CD9 – CD151 inter-
actions ( Fig. 5, A and B ) previously shown by biochemical stud-
ies (for review see  Hemler, 2005 ). In addition, we found that 
CD9 preferentially interacted with ICAM-1 and CD151 with 
VCAM-1, with FRETeff values close to those detected between 
tetraspanins ( Fig. 5, C and D ). In contrast, VCAM-1 – CD9 and 
ICAM-1 – CD151 interactions were scarce throughout the cell 
membrane and were not detected in all cells studied (Fig. S1, 
B and C). These results further support the existence of differential 
molecular interactions in EAPs and strongly suggest that there 
are preferential associations between specifi c adhesion receptors 
 Tetraspanin microdomains are involved 
in the formation of specialized EAPs 
 Because there is no heterophilic ICAM-1 – VCAM-1 interac-
tion, the coclustering of adhesion receptors may involve their 
lateral association with specific plasma membrane micro-
domains. We have previously found that the CD9, CD81, and 
CD151 tetraspanins concentrate at docking structures around 
primary human leukocytes and coprecipitate together with 
VCAM-1 and ICAM-1 ( Barreiro et al., 2005 ). In this study, 
we found that tetraspanin proteins were also enriched at 
docking sites in the K562   4 and LFA-1 adhesion models 
(Fig. S2 A, available at http://www.jcb.org/cgi/content/full/
jcb.200805076/DC1). To examine this association further, we 
engaged endothelial surface proteins with specifi c magnetic 
bead – coated antibodies, fi nding that engagement of either 
CD9 or CD151 corecruited both ICAM-1 and VCAM-1. Con-
versely, beads coated with anti – VCAM-1 corecruited ICAM-1 
and vice versa, and both antibodies clustered tetraspanins. 
In contrast, anti – vascular endothelial cadherin (VE-cadherin) –
 coated beads did not signifi cantly recruit ICAM-1, VCAM-1, 
or tetraspanins above basal levels (Fig. S2, B and C; and 
not depicted). 
 Sucrose gradient fractionation of lysates of TNF-  –
 activated HUVECs showed that most tetraspanins are soluble 
under these conditions and migrate with the dense fractions 
(F1 – F7) together with ICAM-1 and VCAM-1, which were not 
found in lipid raft fractions containing caveolin (Fig. S2 D). 
These results strongly suggest that endothelial tetraspanin 
microdomains containing VCAM-1 and ICAM-1 are distinct 
from classical biochemically defi ned lipid rafts and may con-
stitute specialized, organized membrane structures, which we 
have termed EAPs. 
 Molecular dynamics at EAPs 
 To explore the molecular dynamics of tetraspanins and adhe-
sion receptors at EAPs, we fi rst used FRAP to study the diffu-
sional properties of EGFP-tagged CD9, CD151, VCAM-1, 
and ICAM-1 at the nude apical plasma membrane of HUVECs 
in comparison with the lipid raft marker GPI-EGFP ( Fig. 3 A 
and Table S1, available at http://www.jcb.org/cgi/content/full/
jcb.200805076/DC1;  Sharma et al., 2004 ). The derived appar-
ent diffusion coeffi cient (Table S1) and the immobile fraction 
(1   R) for each protein ( Fig. 3 A ) were calculated. GPI-EGFP 
showed the highest mobility (  1  μ m 2 /s, as previously de-
scribed in  Kenworthy et al., 2004 ). Tetraspanins and ICAM-1 
behaved similarly (D =   0.5  μ m 2 /s), whereas VCAM-1 seemed 
to diffuse slower (D =   0.3  μ m 2 /s) and exhibited a higher im-
mobile fraction. 
 To assess the infl uence of leukocyte adhesion on EAP dy-
namics, FRAP was performed on endothelial docking structures 
induced by engagement of K562   4 or LFA-1 ( Fig. 3, B – D ). The 
most notable effects were when an endothelial adhesion receptor 
was specifi cally bound to its ligand, a greater proportion of the 
protein population remained immobile, and the mobility of the 
residual mobile fraction was locally restricted ( Fig. 3, C and D ; 
and Fig. S3 A, available at http://www.jcb.org/cgi/content/full/
jcb.200805076/DC1). Other nonligated EAP components were 
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(Fig. S4, B and C; and not depicted). In contrast, VE-cadherin 
does not coprecipitate tetraspanins (Fig. S4 B), and its engage-
ment does not induce corecruitment of EAP components (Fig. S2, 
B and C), suggesting its exclusion from these specialized 
membrane microdomains. 
and tetraspanins. In further biochemical and microscopy anal yses, 
we searched for other endothelial receptors that might interact 
with tetraspanins and cluster at the leukocyte – endothelial contact 
area independently of ligand binding, identifying PECAM-1/
CD31, CD44, JAM-A, and ICAM-2 as putative EAP components 
 Figure 3.  EAP component dynamics at nude membrane and 
docking structures. (A) Endothelial cells were transiently trans-
fected with CD9-, CD151-, ICAM-1 – , VCAM-1 – , or GPI-EGFP 
and activated with TNF-  . FRAP curves from comparable 
areas of nude plasma membrane were acquired and ﬁ tted 
by a simple diffusion model. Mean-ﬁ tted ﬂ uorescence re-
covery curves  ± SEM are depicted on the overlay graphic. 
(B) Representative FRAP analysis at an endothelial docking 
structure. Prebleaching image shows an ICAM-1 – EGFP-trans-
fected endothelial cell with docking structures formed around 
attached K562 LFA-1 cells (circles of high ﬂ uorescence). The 
boxed docking structure, shown in the inset at high magni-
ﬁ cation during bleaching, was selected for photobleaching 
recovery. Bar, 20  μ m. (C and D) Mean-ﬁ tted ﬂ uorescence 
recovery curves  ± SEM for ICAM-1 – , VCAM-1 – , CD9-, and 
CD151-EGFP at docking structures (comparable areas) 
formed around K562 LFA-1 or K562   4. (E) Mean-ﬁ tted ﬂ uo-
rescence recovery curves  ± SEM for GPI-EGFP at plasma mem-
brane (PM) or docking structures (DS; comparable areas). 
Immobile fractions calculated from ﬁ tted curves are shown in 
the bar histograms. Statistical analysis and number of exper-
iments are shown in Table S2 (available at http://www.jcb
.org/cgi/content/full/jcb.200805076/DC1). 
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 Figure 4.  EAP component diffusion at nude membrane and docking structures. (A) Representative FCS measurements at plasma membranes of 
transiently transfected primary HUVECs expressing very low levels of CD9-, CD151-, ICAM-1 – , or VCAM-1 – mEGFP. For each condition, the ﬁ gure 
shows the ﬂ uorescence intensity image (kCPS, kilo counts per second), the ACF (black line) derived from the ﬂ uorescence intensity trace acquired 
at the point marked with a white cross, the best-ﬁ tted curve using an anomalous diffusion model (red line), and the diffusion (D) and anomality 
(  ) coefﬁ cients. In the FCS autocorrelation curves, the x axis (  ) represents the delay time in seconds, and the y axis (G(  )) is the autocorrelation 
amplitude as a function of delay time. Box-whisker plots show distributions of D and   values obtained from several transiently transfected HUVEC 
batches using mEGFP and mRFP1 versions of the four proteins; minimum, 25th percentile, median, 75th percentile, and maximum values are shown. 
(B) Representative FCS measurements of CD9-mGFP at the plasma membrane and an endothelial ICAM-1 – mediated docking structure formed around 
an adhered K562 LFA-1 cell. The same parameters described in A are shown. Box-whisker plots compare data from the plasma membrane (repro-
duced from A) with data from docking structures. Statistical analysis and number of experiments are reported in Table S3 (available at http://www.jcb
.org/cgi/content/full/jcb.200805076/DC1). 
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infection ( Zhu et al., 2002 ;  Takeda et al., 2003 ;  Ho et al., 2006 ), and 
VCAM-1 – and ICAM-1 – mediated lymphocyte adhesion strength 
and transmigration under fl ow in vitro ( Barreiro et al., 2005 ). 
However, the mechanism of action of LEL peptides has not been 
elucidated yet. FCS analyses showed that CD9-LEL-GST 
decreased the diffusion of CD9 and CD151 ( Fig. 6, A – C ), suggesting 
that interference with CD9, the most abundant EAP component, 
has a critical effect on EAP organization and dynamics. 
 Role of tetraspanins in the molecular 
dynamics and nanoclustering of adhesion 
receptors in EAPs 
 To investigate the role of tetraspanins in the molecular dynamics of 
EAPs, we used the tetraspanin-blocking peptide CD9 – large extra-
cellular loop (LEL) – GST. Tetraspanin-blocking peptides have been 
used to perturb functions regulated by tetraspanin microdomains, 
such as egg – sperm fusion, monocytic giant cell formation and HIV 
 Figure 5.  Speciﬁ city of molecular interactions in EAP HUVECs transfected with mEGFP – mRFP1 pairs (CD9 – CD9, CD9 – CD151, ICAM-1 – CD9, and VCAM-1 – 
CD151). FRET – FLIM analysis was performed as in  Fig. 2 . For each FRET pair, the ﬁ gure shows the ﬂ uorescence intensity (F. intensity) image (in pseudo-
color scale), the phasor plot, and the FLIM image corresponding to the cursor selection in phasors (black circles), with the location of the highest FRETeff 
population illustrated with the pink mask (14 – 34% FRETeff). a.u., arbitrary units; s, sine; g cosine. Bars, 20  μ m. 
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and ICAM-1 and VCAM-1 adhesion receptors in EAPs, both at 
nude apical membrane and in the docking structures formed be-
tween endothelial cells and adhered leukocytes. Our results show 
that EAPs play an essential role in the spatial organization of the 
membrane and in the recruitment of ICAM-1 and VCAM-1 
toward the contact area with adherent leukocytes, regulating 
endothelial cell adhesiveness ( Fig. 8 , right). 
 The coclustering of VCAM-1 at docking structures induced 
by ligand engagement of ICAM-1 and vice versa initially sug-
gested that these adhesion receptors might interact with each 
other. However, the FRET – FLIM analysis only showed signifi -
cant association for ICAM-1 – ICAM-1, with negligible hetero-
philic interactions between ICAM-1 and VCAM-1. The existence 
of ICAM-1 homodimers has been shown before by biochemical 
approaches ( Miller et al., 1995 ;  Reilly et al., 1995 ). However, 
BIAcore affi nity measurements revealed that a single ICAM-1 
monomer, not dimeric ICAM-1, represents the complete, fully 
competent LFA-1 – binding surface ( Jun et al., 2001 ). 
 The possible role of tetraspanins in the corecruitment of 
these adhesion receptors was confi rmed by additional FRET –
 FLIM analysis, which showed homophilic (CD9 – CD9) and het-
erophilic (CD9 – CD151) tetraspanin interactions as well as 
association of these tetraspanins with the adhesion receptors 
studied. Interestingly, the molecular interactions among tet-
raspanins and adhesion receptors show signifi cant specifi city, 
with a preferential association of CD9 with ICAM-1 and of 
CD151 with VCAM-1. Although full elucidation of the mole c-
ular complexity of EAPs requires additional studies, it is very 
likely that other tetraspanins and adhesion receptors are con-
tained in these structures, interacting among themselves and 
with CD9, CD151, ICAM-1, and VCAM-1. Indeed, our data in-
dicate that tetraspanin CD81 ( Barreiro et al., 2005 ), CD44, 
PECAM-1/CD31, JAM-A, ICAM-2, and E-selectin (Fig. S4, 
B and C; and not depicted) all associate with tetraspanin CD9 
and are included in EAPs. However, further studies are required 
to determine whether there are distinct kinds of EAPs with 
defi ned protein composition. 
 The diffusional behavior of EAP components was investi-
gated by combining FRAP and FCS analyses; FRAP provided a 
qualitative overview of EAP diffusion at a microscopic level, 
and FCS allowed us to accurately quantify diffusion coeffi cients 
of EAP components at the single-molecule level. FRAP anal-
yses indirectly examine the diffusion of an overall molecular 
population within a microscopic area at nude membrane or at 
sites of leukocyte anchorage. Therefore, a mixed steady-state 
molecular population (comprising proteins bound or unbound 
to cytoskeleton, coupled to partners, etc.) is considered for each 
measurement. From FRAP data collected at nude plasma mem-
brane, we distinguished differences between the immobile frac-
tions of VCAM-1 and ICAM-1. These data indicate important 
differences in the binding of these receptors to cortical cyto-
skeleton that deserve further analysis. In this regard, it has 
been described as a direct association of VCAM-1 with ezrin and 
moesin ( Barreiro et al., 2002 ), whereas ICAM-1 interacts with 
 -actinin and colocalizes but does not directly associate with ezrin/
radixin/moesin proteins in endothelial cells ( Romero et al., 2002 ; 
 Celli et al., 2006 ). The higher frequency of transiently immobilized 
 The spatial organization of EAPs was assessed by scan-
ning electron microscopy combined with immunogold label-
ing of VCAM-1 and ICAM-1. We found submicrometer-sized 
homo- and heteroclusters of these adhesion receptors through-
out the nude apical plasma membrane ( Fig. 7 A and  Fig. 8 , 
left), supporting the concept of preexistent EAP microdomains. 
Localized high density clustering was observed at the micro-
villi of docking structures around adherent leukocytes (shown 
for ICAM-1;  Fig. 8 , right), indicating that EAPs coalesce dur-
ing the formation of such structures. Quantifi cation of clusters 
and particles/cluster in cell membrane areas expressing high or 
low content of ICAM-1 and VCAM-1 revealed an increase in 
cluster number in those areas containing higher numbers of ad-
hesion molecules, whereas there was no signifi cant change in 
the number of particles per cluster. EAPs therefore seem to be 
size restricted to nanometric dimensions (apparent mean size of 
  300 nm;  Fig. 7 A and Fig. S5 A, available at http://www.jcb
.org/cgi/content/full/jcb.200805076/DC1). 
 Nearest neighbor analysis of the spatial pattern of immuno-
gold-labeled ICAM-1 and VCAM-1 in the presence of CD9-
LEL-GST showed that receptor spacing was increased compared 
with cells not treated or treated with heat-inactivated peptide 
( Fig. 7 B ). CD9-LEL-GST also reduced the percentage of clus-
tered receptors ( Fig. 7 C ) and partially disrupted their patterned 
distribution on the cell membrane (Fig. S5 B). CD9-LEL-GST 
thus seems to compete with endogenous CD9 for binding to it-
self homophilically and to other tetraspanins and partners, prob-
ably by blocking interactions and imposing steric hindrance, 
resulting in slower diffusion of EAP components and reduced 
receptor clustering, which in turn decreases adhesiveness. 
 Discussion 
 Plasma membranes contain different kinds of organized micro-
domains, all of which play important roles in sensing and process-
ing information from the cell exterior. The composition and 
biophysical properties of lipid rafts, which are based on lipid –
 protein interactions, have been extensively studied ( Kenworthy 
et al., 2004 ;  Sharma et al., 2004 ). Much less is known about 
TEMs, which are primarily based on protein – protein interactions. 
Previous microscopy analysis of fi xed samples and biochemical 
studies indicated that a network of specifi c protein – protein inter-
actions may exist between tetraspanins and associated partners 
( Claas et al., 2001 ;  Nydegger et al., 2006 ). In this study, we have 
used advanced analytical microscopy and single-molecule spec-
troscopy techniques to characterize the dynamic features and bio-
physical properties of TEMs in living primary human endothelial 
cells. Our results provide the fi rst description of tetraspanin micro-
domains as physical entities in living cells with dynamic features 
that clearly differ from lipid rafts. The transiently transfected 
primary human endothelial cells used are a physiologically rele-
vant cell model that expresses an appropriate repertoire of mem-
brane tetraspanins and adhesion receptors. We show that these 
cells bear a particular kind of TEM enriched in membrane adhe-
sion receptors to facilitate leukocyte – endothelial interactions that 
we have termed EAPs ( Fig. 8 , left). Moreover, we have character-
ized the molecular interactions of CD9 and CD151 tetraspanins 
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 Figure 6.  CD9-LEL-GST perturbs EAP dynamics. (A and B) Representative FCS measurements at the plasma membrane of endothelial cells transiently 
cotransfected with CD9-mRFP1 (A) and CD151-mEGFP (B) and treated with 250  μ g/ml active or heat-inactivated CD9-LEL-GST. The ﬁ gure shows the ﬂ uor-
escence intensity image, the ACF (black lines) derived from the ﬂ uorescence intensity trace acquired at the point marked with a white cross, the best-ﬁ tted 
curve using an anomalous diffusion model (red lines), and D and   coefﬁ cients. (C) Box-whisker plots show distributions of D and   values (as in  Fig. 4 ). 
Statistical analysis and number of experiments are presented in Table S3 (available at http://www.jcb.org/cgi/content/full/jcb.200805076/DC1). kCPS, 
kilo counts per second. 
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prototypic lipid raft proteins ( Lenne et al., 2006 ). Moreover, 
GPI-EGFP was unaffected by engagement of integrin-bearing 
leukocytes, whereas EAP dynamics were altered. In fact, the 
delay observed for nonligand-engaged EAP components at 
docking structures could well be the result of their transient in-
teraction with ligand-immobilized ICAM-1 or VCAM-1. These 
immobile complexes at docking sites could thus act as physical 
constraints on the mobility of the overall molecular populations 
analyzed, producing a net restriction in local diffusion. The fact 
that each adhesion receptor is less affected than tetraspanins by 
ligand engagement of the other receptor supports a model of 
tetraspanin-dependent receptor coclustering. The higher relative 
frequency of fast diffusion by tetraspanins indicates that they 
are more dynamically exchanged between EAPs than are adhe-
sion receptors, further supporting their role as the active orga-
nizers of these microdomains. Moreover, adhesion receptors 
molecules in the case of VCAM-1 might produce a decrease in 
the average apparent D coeffi cient for this molecular species 
because FRAP calculations are made on an overall molecular 
population. In fact, these apparent D coefficients fitted by a 
simple diffusion model do not reveal the real diffusional behav-
ior of the receptors, which turned out to be undistinguishable 
when precisely measured by single-molecule FCS analysis fi t-
ted by an anomalous diffusion model. Diffusional analyses by 
FCS thus complement the FRAP data. 
 When we used FRAP to analyze the diffusion of GPI-
EGFP, a lipid raft marker widely used in microscopy studies 
( Varma and Mayor, 1998 ;  Kenworthy et al., 2004 ), we found 
that this protein diffused much faster than tetraspanins and other 
EAP components and showed almost full fl uorescence recovery. 
In addition, most D coeffi cients for EAP proteins that we have 
obtained using FCS are much lower than those reported for 
 Figure 7.  Tetraspanins regulate endothelial adhesion receptor nanoclustering. (A) TNF-  – activated endothelial cells were ﬁ xed and stained with anti –
 VCAM-1 or anti – ICAM-1 followed by 40-nm gold immunolabeling. Representative scanning electron microscope negative images of the endothelial plasma 
membrane are shown. Mean cluster number and size  ± SEM for VCAM-1 – and ICAM-1 – containing microdomains analyzed in images with low or high 
particle number (i.e., indirect measurement of low or high receptor expression). Clustering parameters:   = 100 and   = 1 (see Materials and methods). 
(B) Gold particle coordinates from individual scanning electron microscope images (15- μ m 2 plasma membrane) were used to compute nearest neighbor 
distances (see Materials and methods). Graphs show comparison of VCAM-1 or ICAM-1 nanoclustering based on nearest neighbor proﬁ les from control, 
CD9-LEL-GST – , and heat-inactivated CD9-LEL-GST – treated samples with statistically comparable numbers of particles. The bar plot represents the mean 
of the Euclidean distance of the nearest neighbor for the total of  n particles in the several images analyzed for each treatment. (C) Clustering rates were 
computed from the samples in B (see Materials and methods). Clustering parameters: VCAM-1,   = 205 and   = 2; and ICAM-1,   = 140 and   = 2. 
Statistical signiﬁ cance in the ﬁ gure was based on a Student ’ s  t test. 
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with ICAM-1 – ICAM-1 interactions, which supports the cen-
tral role of tetraspanins in the molecular dynamics of adhesion 
receptors, strengthening the concept of EAPs as the basic or-
ganizational unit of endothelial adhesion receptors on the apical 
plasma membrane. 
 The regulation of endothelial adhesion receptor avidity by 
their inclusion in tetraspanin-enriched EAPs represents a con-
ceptual advance in the understanding of leukocyte – endothelium 
interactions. Leukocyte integrin activity can be regulated by 
conformational changes (affi nity) and/or clustering at the plasma 
membrane (avidity;  Luo et al., 2007 ). In contrast, no regulatory 
mechanism apart from transcription has been described before 
for endothelial integrin ligands ( Collins et al., 1995 ). Our data 
demonstrate that tetraspanin and adhesion receptor colocalization 
does indeed refl ect highly specifi c and organized interactions 
among them, forming specialized TEMs (EAPs;  Fig. 8 , left and 
middle panels illustrate preformed EAPs). Inclusion of ICAM-1 
and VCAM-1 in EAPs allows homo- and heteroclustering of 
exhibit a higher anomality in diffusion, which accounts for their 
preferential binding to cortical cytoskeleton and transient im-
mobilization compared with tetraspanins ( Sala-Valdes et al., 
2006 ). However, further studies are needed to defi ne the resi-
dence time of molecules within EAPs. The mix of endogenous 
and exogenous protein populations precludes precise determina-
tion of the stoichiometry of submicrometer-sized EAPs. Nonethe-
less, analysis of brightness from the photon-counting histograms 
obtained during FCS measurements revealed the existence of com-
plexes containing more than one fl uorescently labeled molecule. 
This was also confi rmed by fl uorescence cross-correlation spec-
troscopy analysis (unpublished data). 
 FRET analysis confi rmed a degree of specifi city inside 
the preexistent EAPs before leukocyte binding. The preferen-
tial interactions of ICAM-1 with CD9 and VCAM-1 with 
CD151 are evident in the FRETeff for these pairs. FRET –
 FLIM analysis shows that interactions between tetraspanins 
and tetraspanin adhesion receptors are more frequent compared 
 Figure 8.  Scheme of tetraspanin-enriched EAPs and docking structures. (top middle) Scanning electron microscopy image of a peripheral blood lympho-
cyte interacting with the apical membrane of an endothelial cell under ﬂ ow conditions. The green square marks a zone of nude membrane containing EAPs 
as shown at high magniﬁ cation in the left panel. The red square highlights the endothelial docking structure, as shown at a nanometric scale in the right 
panel. EAPs are preformed nanoclusters that serve as nucleating units for integrin ligands and their tetraspanin partners, whereas docking structures are 
microscopic clusters of EAPs organized in microvilli around adherent leukocytes. (bottom middle) Immunoﬂ uorescence staining showing the macroscopic 
appearance of EAPs and docking structures. K562 LFA-1 was adhered (30 min) to TNF-  – activated HUVECs. Samples were ﬁ xed and double stained with 
anti – PECAM-1 and biotin-conjugated anti – ICAM-1. Confocal stacks were obtained, and an orthogonal maximal projection is displayed. Microscopic-sized 
clusters of EAPs in this image. (left) Activated endothelial cells were ﬁ xed and double stained with 40 nm VCAM-1 and 15-nm ICAM-1 gold particles. The 
panel shows a representative negative scanning electron microscopy image from the nude apical endothelial plasma membrane. The white asterisks mark 
the 15-nm anti – ICAM-1 gold particles, and the black dots are the 40-nm anti – VCAM-1 gold particles. The white boxes depict regions of VCAM-1 – ICAM-1 
heteroclustering, whereas the black box shows an ICAM-1 homoclustering zone. (right) T lymphoblasts were adhered to activated endothelial cells (5 min). 
Fixed cells were stained with anti – ICAM-1 and 40-nm immunolabeled gold. A representative negative scanning electron microscopy image shows the 
preferential localization of gold particles at the microvilli of the endothelial docking structure formed around a lymphoblast, where EAPs coalesce. 
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inhibitors BIO5192 and BIRT377 were provided by Biogen Idec and 
Boehringer Ingelheim, respectively. 
 Antibodies 
 Anti-CD151 (LIA1/1), anti – VE-cadherin (TEA1/31), and anti-CD9 (VJ1/20) 
mAbs have been described previously ( Yanez-Mo et al., 1998 ). P8B1 (anti –
 VCAM-1), MEM-111 and Hu5/3 (anti – ICAM-1), and 8C3 (anti-CD151) 
mAbs were provided by E.A. Wayner (Fred Hutchinson Cancer Research 
Center, Seattle, WA), V. Horejsi (Academy of Sciences of the Czech Repub-
lic, Prague, Czech Republic), F.W. Luscinskas (Brigham and Women ’ s Hospi-
tal, Harvard Medical School, Boston, MA), and K. Sekiguchi (Osaka 
University, Osaka, Japan), respectively. Anticaveolin antibody was purchased 
from Sigma-Aldrich. 
 Recombinant DNA constructs and proteins and transfections 
 EGFP-tagged ICAM-1, VCAM-1, CD9, and CD151 have been previously de-
scribed ( Barreiro et al., 2002, 2005 ;  Garcia-Lopez et al., 2005 ). The con-
struct encoding VCAM  Cyt, a C-terminally truncated VCAM-1 protein in 
which the ﬁ rst cytoplasmic charged residue is retained to ensure proper mem-
brane insertion, was generated by PCR using the human VCAM-1 cDNA as 
template and CTCGAGTCTCATCACGACAGCAAC and CTATCTTGCAAAG-
TAAATTATC as 5 	 and 3 	 primers, respectively. The PCR product containing a 
stop codon at position 1722 was cloned into pcDNA3.1/V5-His-TOPO (Invit-
rogen), and correct expression of VCAM  Cyt at the plasma membrane was 
tested. The equivalent ICAM-1 – tailless construct, but fused to EGFP, was pro-
vided by F.W. Luscinskas. For FCS and FRET – FLIM experiments, monomeric 
green and red variants of ICAM-1, VCAM-1, CD9, and CD151 were gener-
ated. mEGFP constructs were obtained by A206K point mutation ( Zacharias 
et al., 2002 ;  Zhang et al., 2002 ) using the Quick Mutagenesis kit (Strata-
gene). The mRFP1 variants were generated by subcloning the corresponding 
EGFP constructs into an mRFP1 vector provided by R.Y. Tsien (University 
of California, San Diego, La Jolla, CA;  Campbell et al., 2002 ). The GPI-EGFP 
construct was provided by M.A. del Pozo (Centro Nacional de Investigaciones 
Cardiovasculares, Madrid, Spain). The LEL of GST-fused human CD9 wild type 
was obtained as described previously ( Barreiro et al., 2005 ). 
 HUVECs were transiently transfected by electroporation ( Barreiro 
et al., 2005 ) or with lipofectin (Invitrogen) according to the manufacturer ’ s 
protocol. Transfected cells were grown to conﬂ uence for 24 – 48 h on 20  μ g/ml 
ﬁ bronectin (FN; Sigma-Aldrich)-precoated glass coverslips or glass-bottomed 
dishes (WillCo Wells). Activation with 20 ng/ml TNF-  was performed 
for 20 h unless indicated otherwise. 
 Cell adhesion, immunoﬂ uorescence, and confocal microscopy 
 Conﬂ uent HUVECs on FN-coated coverslips were activated with TNF-  . 
Then, K562 clones or T lymphoblasts were added. Adhesion of K562 LFA-1 
to activated HUVEC monolayers was assayed in the presence of 1 mM 
Mn 2+ to activate integrins. Where indicated, T lymphoblasts were treated 
with 10  μ g/ml BIO5192 or 10  μ M BIRT377 for 5 min before adhesion as-
say. After incubation, samples were washed and ﬁ xed in 4% paraformal-
dehyde and processed for immunoﬂ uorescence ( Yanez-Mo et al., 1998 ). 
A series of optical sections were obtained at 21 ° C with a confocal laser-
scanning unit (TCS-SP5; Leica) coupled to a microscope (DMI6000; Leica) 
using an HCX PL APO CS 63 × NA 1.3 glycerol immersion objective. 
Images were analyzed with confocal software (Leica). 
 Bead adhesion 
 TNF-  – activated HUVECs were incubated for 30 min with Dynabeads 
coated with antitetraspanin, anti – VCAM-1, or anti – VE-cadherin mAb 
(Invitrogen) and were ﬁ xed and stained with biotinylated anti – ICAM-1 mAb. 
 Sucrose density gradient fractionation 
 Conﬂ uent TNF-  – activated HUVECs were rinsed with PBS and lysed for 
20 min in 250  μ l of 25 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 1% 
Brij96 at 4 ° C. The cell lysate was homogenized by passing the sample 
through a 22-gauge needle. The extract was brought to 40% sucrose 
(wt/wt) in a ﬁ nal volume of 4 ml and placed at the bottom of an 8-ml 
5 – 30% linear sucrose gradient. Gradients were ultracentrifuged to equilib-
rium for 20 h at 39,000 rpm at 4 ° C in a rotor (SW41; Beckman Coulter). 
1-ml fractions were harvested from the bottom of the tube. Aliquots from 
each fraction were subjected to SDS-PAGE and Western blotting with ap-
propriate antibodies. 
 FRAP 
 Cells transfected with EGFP fusion proteins (VCAM-1 – , ICAM-1 – , CD9-, 
CD151-, ICAM-1  Cyt – , and GPI-EGFP) were plated on FN-coated coverslips. 
both molecules at the contact area with the adhered leukocyte 
independent of ligand binding and actin cytoskeleton anchorage 
( Fig. 8 , right and middle panels illustrate a docking structure 
around the adhered leukocyte). This novel role of tetraspanins 
seems to represent a supramolecular level of regulation not pre-
viously envisaged for integrin ligands. Additional tetraspanin 
molecules could be involved in regulating the molecular dy-
namics and organization of EAPs, among them CD81, which is 
also localized at endothelial docking structures ( Barreiro et al., 
2005 ) and which, in leukocytes, is able to act as a homeostatic 
avidity facilitator of VLA-4 ( Feigelson et al., 2003 ). 
 The important role of tetraspanins in the molecular dynamics 
of EAPs is also supported by our results with the CD9-LEL-GST –
 blocking peptide. It seems evident that this CD9-blocking peptide 
perturbs EAP dynamics by competing with endogenous CD9 for 
binding to partners and other tetraspanins. As CD9 is the most 
abundant of the analyzed EAP components, intercalation of CD9-
blocking peptides into EAPs would alter the patterned distribution 
and mobility of all the proteins embedded within them, providing 
an explanation for the decrease in receptor-binding strength. EAPs 
thus appear to endow ICAM-1 and VCAM-1 with the proper spa-
tial distribution to exert their adhesive functions, promoting their 
clustering and, therefore, enhancing their avidity for their ligands 
expressed on leukocytes. Supramolecular organization at the nano-
scale has been reported for other receptor molecules, including 
LFA-1 integrin on leukocytes and the C-lectin receptor dendritic 
cell – specifi c ICAM-grabbing nonintegrin on dendritic cells ( Cairo 
et al., 2006 ;  Cambi et al., 2006 ;  de Bakker et al., 2007 ). Whether 
these molecules are included within TEMs on the leukocyte plasma 
membrane is an interesting issue that deserves investigation. 
 With the reagents currently available, it is not possible to 
address whether endothelial receptors undergo conformational 
change because of their interaction with tetraspanins. However, 
it will be of interest to identify the critical amino acid sequences 
in tetraspanins and adhesion receptors that participate in their 
lateral interactions. This information would have potential use 
in the future design of therapeutic blocking agents directed at 
reducing the adhesiveness of endothelial cells toward circulat-
ing leukocytes. Such agents might provide novel therapeutic 
strategies for the treatment of chronic infl ammatory and auto-
immune diseases in a more general manner than existing ther-
apies focused on the inhibition of a particular adhesion pathway 
mediated by a single integrin ligand. 
 In summary, our data indicate that EAPs are specialized 
tetraspanin-based membrane microdomains that regulate the 
avidity of several adhesion receptors integrated in them, acting 
as a mechanism to organize molecules with similar characteris-
tics and functions and thereby facilitating their coordinated ac-
tion in rapidly occurring processes such as extravasation. 
 Materials and methods 
 Cells 
 HUVECs were cultured as described previously ( Barreiro et al., 2002 ). 
K562 erythroleukemic cells, which endogenously express   1 integrin, 
were stably transfected with integrin   4 to yield cells expressing   4  1 
integrin/VLA-4 or with integrin   L  2/LFA1. K562 clones and T lymphoblasts 
were cultured as described previously ( Barreiro et al., 2002 ). Integrin 
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quenched by 50% FRET in the presence of the acceptor and with different 
contributions from cell autoﬂ uorescence (red line in all phasor plots). In all of 
our experiments, phasors resulting from any combination of unquenched do-
nors, FRET-quenched donors, and cell autoﬂ uorescence have been found 
within the area delimited by the green and red lines in the phasor plots. 
The localization and distribution of the phasors of mEGFP constructs were not 
affected by the kind of protein linked to the ﬂ uorophore or by the cells in 
which they were expressed. Endogenous untagged proteins expressed in 
our cell model may interfere with FRET. To minimize interaction between en-
dogenously and exogenously expressed tagged proteins in FLIM analyses, 
quantiﬁ cations were performed in resting endothelial cells, where tetraspanin 
expression is unaltered, ICAM-1 levels are low, and VCAM-1 plasma mem-
brane expression is negligible. Given that endogenous CD151 and CD9 ex-
pression is much higher than ICAM-1 in resting endothelial cells, FRETeff from 
measurements involving tetraspanin proteins may be underestimated. More-
over, because CD9, CD151, and ICAM-1 can homodimerize, the associa-
tion of two green or red molecular species makes hetero-FRET events even 
more improbable. To substantiate the experimental data on the absence of 
ICAM-1 – VCAM-1 heterodimers, ICAM-1 or VCAM-1 was used indistinctly 
as a donor in FRET – FLIM experiments. 
 FCS 
 HUVECs were transiently single or double transfected as for FLIM and 
treated either with growth factors (resting conditions) or with 20 ng/ml 
TNF-  (activated conditions). Intensity ﬂ uctuations were recorded on the 
described setup ( Caiolfa et al., 2007 ) based on a dual-channel confocal 
ﬂ uorescence correlation spectrometer (ALBA; ISS, Inc.) equipped with 
avalanche photodiodes (SPCM-AQR-15; PerkinElmer) and interfaced to 
an inverted microscope (TE300; Nikon). A 60 × 1.2 NA plan Apo water 
immersion objective was used. Excitation was provided at 488 nm by a 
tunable Ar ion laser (Melles Griot) and at 594 nm by a HeNe laser (Melles 
Griot). Calibration and data collection were performed according to the 
procedures previously described ( Caiolfa et al., 2007 ). 
 The ACFs were best ﬁ tted using the anomalous diffusion model 
( Banks and Fradin, 2005 ), according to the equation 
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 where N is the average number of molecules in the excitation volume,   is 
the increment of time,   D is the diffusion time, and   is the anomality coefﬁ -
cient. Accordingly, the diffusion coefﬁ cient (D) is derived from the relation-
ship D =  
 2 /4     . 
 In FCS experiments, endogenous proteins were in excess com-
pared with corresponding ﬂ uorescent-tagged variants, minimizing arti-
facts as a result of differences in local concentrations of the latter. FCS 
experiments were performed both either in resting or in TNF-  – activated 
HUVECs, not ﬁ nding statistically signiﬁ cant differences in diffusion be-
tween the treatments. 
 Scanning electron microscopy 
 Endothelial monolayers were activated with TNF-  in the absence or pres-
ence of 250  μ g/ml of active or heat-inactivated (5 min at 90 ° C) CD9-LEL-GST 
peptide. T lymphoblasts were added when indicated. Cells were ﬁ xed 
in 2% paraformaldehyde/PBS and immunolabeled with P8B1 (anti –
 VCAM-1), Hu5/3 (anti – ICAM-1), or biotinylated MEM-111 (anti – ICAM-1) 
as primary antibodies and 40 nm of gold-coupled anti – mouse antibody or 
15 nm of gold-coupled streptavidin (British Biocell International) as detec-
tion reagents. Samples were ﬁ xed in 2.5% glutaraldehyde/PBS, sequen-
tially dehydrated, critical point dried, and covered with a 5-nm carbon 
layer. Images were obtained with a scanning electron microscope 
(S-4100; Hitachi) at an acceleration voltage of 12 kV and a 4-mm work-
ing distance. Images were processed with Metamorph software (MDS 
Analytical Technologies). 
 Nearest neighbor distances and k nearest neighbor (knn) proﬁ les 
 For each image, we computed the knn distance vector that contains in its i th 
position the mean of the distances between objects and their i th nearest 
neighbor. Comparison of knn proﬁ les allows us to establish similarities and 
discrepancies between different treatments in terms of aggregation and dis-
persion of the clouds of points in the image. The knn distances were assumed 
to be independent realizations of a normal distribution (the null hypothesis of 
normality could not be rejected using a Shapiro-Wilk test). Because the knn pro-
ﬁ le might be dependent on the number of objects, the analysis was performed 
After 24 h, cells were stimulated with TNF-  , and FRAP experiments were per-
formed within 48 h of plating. To analyze FRAP at the endothelial docking 
structure, an adhesion assay was conducted using K562   4 or LFA-1. Live cell 
microscopy was performed with a confocal laser-scanning unit (TCS-SP2; 
Leica) coupled to a microscope (DMIRBE; Leica) using the 488-nm Ar laser line 
and an HCX PL APO lambda blue 63 × NA 1.4 oil immersion objective. Dur-
ing observation, plates were maintained at 37 ° C in a 5% CO 2 atmosphere 
using an incubation system (LaCon GbR/PeCon GmbH). Laser power for 
bleaching was maximal but was reduced to 10% for imaging. 10 single-section 
prebleach images were acquired followed by three iterative bleach pulses 
of 1.7 s each. 10 single-section images were then collected at 1.7-s intervals 
followed by 20 images every 10 s and ﬁ nally 15 images every 30 s for a total 
experimental time of   650 s. 
 Fluorescence recovery in the bleached region was measured as aver-
age signal intensity. All recovery curves were generated from background-
subtracted and bleaching-corrected images. Moreover, the ﬂ uorescence signal 
was normalized to the prebleach signal in the same region of interest. 
 The mobile fraction (R) corresponds to the ﬁ nal value of the recov-
ered ﬂ uorescence intensity, and the immobile fraction is obtained as 1   R. 
The half-time of recovery is the time from bleaching to the time when the 
ﬂ uorescence intensity is half of the ﬁ nal recovered intensity. All three varia-
bles were directly obtained from the normalized mean ﬂ uorescence 
recovery curves. 
 The averaged recoveries were ﬁ tted with the equation 
  F(t) F (R F F F t/
t/
,0
0
0 0 1/2
1/2
=
+ ´ - + ´
+
( ) ) ( )
( )
t
t1
  
 where F 0 = ﬂ uorescence intensity at the ﬁ rst time point after bleach, F 0 = 
ﬂ uorescence intensity before bleach, R = mobile fraction, and  t 1/2 = half re-
covery time. Apparent diffusion coefﬁ cients from averaged recovery half-
times were derived using a simple Brownian diffusion model. Averaged 
immobile fractions (1   R) were derived from averaged ﬁ tted curves. 
 The possible perturbation of membrane dynamics that might result 
from differential exogenous expression of tagged proteins was overcome 
in FRAP experiments by making a large number of measurements in several 
batches of transiently transfected primary endothelial cells and exhaustive 
statistical analysis. To assess the statistical signiﬁ cance of differences be-
tween FRAP recovery curves, we derived a  t test analysis on the average 
ﬁ tted curves for each protein in each condition. 
 Hetero-FRET by donor FLIM in intact living cells 
 HUVECs were single transfected with mEGFP standards or cotransfected 
with mEGFP – mRFP1 pairs and seeded on FN-coated glass-bottomed 
dishes. After 24 h and without TNF-  treatment, the culture medium was re-
placed with a phenol red – free medium for optimal image acquisition. FLIM 
was performed using the digital frequency domain method and the new 
FLIM box, recently described in detail ( Colyer et al., 2008 ), which were 
implemented at the Laboratory of Fluorescence Dynamics (University of 
California, Irvine, Irvine, CA) on a commercial confocal system (FluoView 
1000; Olympus). Excitation was provided by a modulated 471-nm diode 
laser (ISS, Inc.). A 40 × 1.2 NA water immersion objective (Carl Zeiss, Inc.) 
was used. Data were acquired and processed by SimFCS software (devel-
oped at the Laboratory of Fluorescence Dynamics). The scan area (256  × 
256 pixels) corresponds to 32  × 32  μ m 2 . Before cell measurements, con-
centrated ﬂ uorescein at pH 9.0 was measured. Fluorescein lifetime (4.04 ns) 
was determined separately in a ﬂ uorometer (PC1; ISS, Inc.). 
 The FLIM analysis for deriving FRETeff was performed using the pha-
sor FLIM method recently described ( Caiolfa et al., 2007 ;  Digman et al., 
2008 ) and commented on ( Wouters and Esposito, 2008 ). The contour plots 
associated with each image show the entire distribution of the donor ﬂ uo-
rescence lifetimes in the image. The distribution was obtained by converting 
the multiexponential ﬂ uorescence decays acquired in each pixel into the 
graphical representation of a phasor. In brief, the phasor transformation 
does not assume any ﬁ tting model for ﬂ uorescence lifetime decays. It simply 
expresses the overall decay in each pixel in terms of a point of (s, g) polar 
coordinates in the so-called  “ universal circle ” ( Redford and Clegg, 2005 ). 
In each plot, the green line represents the position of all phasors having 0% 
FRETeff and variable cellular autoﬂ uorescence. These points were derived 
from the lifetime analysis in cells expressing only the donor molecules, 
whereas untransfected cells were used as a control for autoﬂ uorescence. 
Once the phasors of the unquenched donors and of the cell autoﬂ uorescence 
(green line in the phasor plots) are known, the FRET trajectory in the phasor 
plot can be calculated according to the classical relationship FRETeff = 
[1   (  donor – acceptor )/  donor ] and deﬁ ne the mean phasors of mEGFP constructs 
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 Cluster and statistical signiﬁ cance 
 The dissimilarities between clustered point patterns for different images 
were established in terms of the proportion of aggregation, deﬁ ned for a 
given image, I v , as the proportion of gold particles, p v , that are included 
in any cluster identiﬁ ed in I v . To identify the cluster pattern of I v , a cluster 
agglomerative algorithm based on Euclidean distances between points 
was developed and implemented in R language. In the way that the clus-
ters are deﬁ ned, the minimum size of the cluster is   + 1. The algorithm 
allows the formation of clusters of any shape, retaining points that are 
close enough to each other to be considered as aggregated. This mini-
mum distance at aggregation is set by the parameter   . The criteria to se-
lect different values for   and   parameters were based on the differential 
number of particles in the images used for the various analyses. For every 
image, I v , and corresponding   and   , a point cluster pattern is identiﬁ ed, 
and the proportion of points, p v , that are included in any cluster is com-
puted. Then, the differences between families of images can be estab-
lished in terms of the different proportions, p v . The statistical signiﬁ cance 
among families of images was assessed with a Student ’ s  t test using the 
asin transformation of p v as arcsin( ).pv  
 Spatial randomness 
 To statistically assess whether the points in a given image are located in 
random positions, we followed the method for testing spatial randomness 
previously described ( Manly, 1997 ). We computed the knn vector for each 
observed image. The null hypothesis knn vector was generated by simulat-
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